Jochen Taupitz
Jochen Taupitz is the director of the Institute of German, European, and International Medical Law at the Universities of Heidelberg and Mannheim. He has provided insights into the legal and ethical implications of mitochondrial replacement therapy, discussing the complexity of germline interventions and the potential need to reevaluate existing laws in Germany in light of advancements in this area.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Germany | 1 | 5.00 | 0.06% | +0% | 83,783,942 | 50,809 | $3,845,000 | 2,332$ |
| Totals | 1 | 83,783,942 | 50,809 | $3,845,000 | 2,332$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Germany:
Jochen Taupitz discusses the legal implications of mitochondrial exchange in Germany.
5